COMP <GO>
ORGO vs NRXP // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Organogenesis Holdings Inc. (Class A) (NASDAQ) VS. NRX Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: ORGO 5
— NRXP 2
■ METRIC PARITY
LAST: $0.76 (-1.64%) • MKT CAP: $97.2M
options-implied-move
—
LAST: $2.17 (-4.40%) • MKT CAP: $94.0M
options-implied-move
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ORGO VS. NRXP)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ORGO | NRXP | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 58.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 17.10% | -35.00% | +52.10 | ORGO | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -23.21% | -12.25% | -10.96 | NRXP | /fcf-yield <GO> |
| Operating Margin | 7.90% | -60.00% | +67.90 | ORGO | /operating-margins <GO> |
| Net Profit Margin | 6.60% | -60.00% | +66.60 | ORGO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.00% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.09 | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 4/9 | 2/9 | +2.00 | ORGO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 19.8 | 30.0 | -10.20 | NRXP | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $97.2M | $94.0M | $3.3M | ORGO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ORGO REV | NRXP REV | ORGO GROSS % | NRXP GROSS % | ORGO FCF | NRXP FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $564.2M | $1.2M | — | 58.8% | -$24.5M | -$14.1M |
| FY 2024 | $482.0M | $51.8M | 76.0% | — | $4.2M | -$10.6M |
| FY 2023 | $433.1M | $77.9M | — | — | $30.9M | -$21.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ORGO // BETA —
NRXP // BETA —